Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 877 results for "daiichi sankyo"

Top heads to roll soon at Ranbaxy
Business Standard India

Daiichi Sankyo's moments of glory

Six years ago, when Daiichi Sankyo, the Japanese pharmaceutical giant, concluded the biggest ever foreign acquisition of an Indian manufacturing company by any group in a $4.2 billion cash deal buying the entire 34.82 per cent stake of Malvinder ... The Echo Of India, 6 days ago
Sun-rise over Modi Business Standard, 1 week ago

122 images for daiichi sankyo

UPI, 1 week ago
Fidelity Brokerage Services LLC, 1 week ago
Financial Express, 1 week ago
NDTV, 1 week ago
4 Traders, 2 weeks ago, 6 days ago, 6 days ago
Yahoo! News Australia, 1 week ago, 1 week ago, 1 week ago

Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.

/PRNewswire/ -- Daiichi Sankyo, Inc. announced today that Ken Keller will join the company as President of its Commercial operations in the United States starting May 1, 2014. In his role, Mr. Keller will be responsible for leading marketing, sales, ...
 BusinessWeek2 days ago Ken Keller Named President, U.S. Commercial, Daiichi Sankyo, Inc.  BioSpace2 days ago
Money Control

DAIICHI SANKYO : Ranbaxy-sun merger deal may close by 2014-end: daiichi

04/15/2014 | 02:41am US/Eastern Recommend: Daiichi Sankyo of Japan , which holds majority stake in Ranbaxy Laboratories Ltd (RLL), has said that the $4 billion merger deal of RLL with Sun Pharma is expected to close by the end of ...
 4 Traders5 days ago Daiichi Sankyo lays out road map for Ranbaxy deal with Sun  FiercePharma1 week ago Ranbaxy-Sun Pharma merger deal may close by year-end: Daiichi  Business Line1 week ago Ranbaxy-Sun Pharma deal to close by 2014 end, says Daiichi  New Delhi Pioneer1 week ago

Rising Sun

The takeover of Daiichi Sankyo-owned Ranbaxy, India’s largest pharmaceutical firm, by Sun Pharma in an all-stock deal worth nearly $4 billion is not only the largest deal in pharma in Asia but has catapulted Sun Pharma to becoming the world’s fifth ...
 Asian Age1 week ago

LDC Forms Early Drug Discovery Alliance with Daiichi Sankyo 2014-04-19 Dortmund, Germany, April 19, 2014 --( )-- The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), Japan, have teamed up to discover ...
 BizWire Express1 day ago DAIICHI SANKYO : and UCSF announce collaboration in research for neurodegenerative diseases  4 Traders4 days ago Daiichi Sankyo Partners With UCSF To Develop Neurodegenerative Drugs  Bioresearch Online1 week ago Daiichi Sankyo and UCSF collaborate for neurodegenerative disease research  Individual.com1 week ago
Nikkei Asian Review

With little patience & luck, Daiichi could come good on second bet

Japanese drugmaker Daiichi Sankyo Co, which offloaded its stake in Ranbaxy to Indian generic major Sun Pharmaceutical for $2.02 billion in exchange for a 9 per cent stake in the latter and no cash, might take up to 42 months to recoup its loss from the ...
 The Financial Chronicle1 week ago Series of import bans, loss of credibility made Daiichi cut and run?  Economic Times1 week ago Daiichi Sankyo to end 6-year Ranbaxy debacle with sale  Nikkei Asian Review1 week ago Kyodo news summary -9-  Pharmacy Choice1 week ago

Ranbaxy gets a new owner

Daiichi Sankyo of Japan had bought the Singh family's 34.8 per cent stake in Ranbaxy Laboratories for $2.4 billion in mid-2008, which put a value of $6.9 billion on the Indian drug maker. The acquisition of Ranbaxy by Sun Pharmaceutical Industries ...
 Smart Investor1 week ago
Business Standard India

Sun hasn't bought a lemon

, what seems to have caught everybody's attention is the massive erosion in value. Daiichi Sankyo of Japan had paid $4.2 billion for a 63.8 per cent stake in the company in 2008; once the deal is closed, it will own nine per cent in Sun Pharma, ...
 Business Standard India1 week ago Bhupesh Bhandari: Sun hasn't bought a lemon  Sify1 week ago

Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

8:00am BST Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd (Ranbaxy) For the full text of this story please click the following
 Reuters UK1 week ago Daiichi Sankyo will benefit from Sun Pharma's acquisition of Ranbaxy: Moody's  Myiris1 week ago
Financial Express

Ranbaxy Laboratories sale reality check for cos from land of the rising sun

Daiichi Sankyo has just reminded corporate Japan of the dangers of overseas adventures. The drugmaker is handing control of its ailing Indian affiliate Ranbaxy to local rival Sun Pharmaceutical in a $3.2-billion deal. The investment has lost almost ...
 Financial Express1 week ago Ranbaxy Sale Shows Risk in Japanese M&A Adventures  New Indian Express1 week ago Ranbaxy Laboratories sale shows risk in Japanese MandA adventures  INooz1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
Get updated on latest news & your favorite topics right in your inbox!
More     Less